💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Amicus Therapeutics, Inc. (FOLD)
« Back to company indexFOLD Chatter Timeline
Stock Ticker for FOLD
Most Active Tweeters for FOLD
| User | Tweets |
|---|---|
| @swapski | 6 |
| @TradeWithAlerts | 6 |
| @Tickeron | 6 |
| @quantisnow | 4 |
| @0ffTrail | 4 |
Recent Tweets for FOLD
 |
@RandomTask555 @LordBogdanoff $FOLD is like 2.5x off the recent lows but still only 5-6m MC. Big MEV play, did you pick some up yet? August 4th 2021, 11:08pm |
 |
@Shill_Pill @DialMonkey @UniHax0r Manifold $fold. Big sleeper in my opinion. They have big things brewing with $Sushi August 4th 2021, 9:08pm |
 |
@InsiderForms $FOLD Insider WHITMAN BURKE W has Purchased 1,500 Shares. Title :Director Total Cost: $13,920.0 Buy/Sell : Buy (10… https://t.co/k6VdlqQwO0 August 4th 2021, 9:08pm |
 |
@Tickeron Amicus Therapeutics Inc to report earnings on August 05, 2021. Earnings per share (EPS) estimate: $-0.22 $FOLD… https://t.co/aI2baXdlSj August 4th 2021, 9:08pm |
 |
@KillswitchNb $sushi + $fold = refund It’s kind of a big deal you know. https://t.co/8nQ0mhoJ5N August 4th 2021, 6:08pm |
 |
@HereticCrypto RT @0ffTrail: DYOR but this is next. Be early. $fold + $sushi @foldfinance https://t.co/HbaOvSuB3h August 4th 2021, 6:08pm |
 |
@BullishSight $FOLD Good day so far today with ER tomorrow. Now above the 50EMA. A close above will be very bullish sentiment.… https://t.co/06LuG4BDmB August 4th 2021, 6:08pm |
 |
@Estimize $FOLD reports before the open tomorrow, Estimize Consensus -0.02 EPS and +1.89M Revs compared to WS - https://t.co/ZpboyDJ4Qg August 4th 2021, 6:08pm |
 |
@SwingTradeBot Rose Above 50 DMA today: $FOLD ... https://t.co/qwiJH6vr1O August 4th 2021, 5:08pm |
 |
@brenbto $fold long here August 4th 2021, 5:08pm |
 |
@TradeWithAlerts Large Print $FOLD Size: 499400 Price: 9.6 Time: 1300 Amount: $4,794,240.00 - Delayed - For real time prints subscri… https://t.co/Y45UcI8yAE August 4th 2021, 5:08pm |
 |
@MarcJacksonLA $FOLD Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference https://t.co/sz8ps0FVxk August 4th 2021, 4:08pm |
|
@KillswitchNb RT @0ffTrail: Effectively FREE trading is coming to eth mainnet on $sushi this month and no one is talking about it… ????? $fold August 4th 2021, 2:08pm |
 |
@0ffTrail Effectively FREE trading is coming to eth mainnet on $sushi this month and no one is talking about it… ????? $fold August 4th 2021, 1:08pm |
|
@0ffTrail DYOR but this is next. Be early. $fold + $sushi @foldfinance https://t.co/HbaOvSuB3h August 4th 2021, 12:08pm |
 |
@FlashAlert_me $FOLD [15s. delayed]: Issued Press Release on August 04, 07:00:00: Amicus Therapeutics to Present at the BTIG Virtu… https://t.co/Az2hFXH7RP August 4th 2021, 11:08am |
 |
@StockNewsBot2 $FOLD Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference https://t.co/5sqC4eKJ6q August 4th 2021, 11:08am |
 |
@quantisnow $FOLD ? Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference https://t.co/7fLqErzz2z 30s delayed. August 4th 2021, 11:08am |
 |
@stock_titan $FOLD Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference https://t.co/f37uCc4NRt August 4th 2021, 11:08am |
 |
@bthefirsttoknow $FOLD: Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference //First out https://t.co/9EpJbE9Zne August 4th 2021, 11:08am |
|
@Tickeron $FOLD's price moved below its 50-day Moving Average on July 2, 2021. View odds for this and other indicators:… https://t.co/F0fcokyT9J August 4th 2021, 9:08am |
 |
@0ffTrail Frontrun protection, revenue sharing, eth-less trading, and $sushi integration huh? Ok then @foldfinance $fold August 3rd 2021, 6:08pm |
 |
@Gambiste1 RT @0ffTrail: @corleonescrypto MEV protection. $BPRO - lending $FOLD - swaps August 3rd 2021, 1:08pm |
|
@0ffTrail @corleonescrypto MEV protection. $BPRO - lending $FOLD - swaps August 3rd 2021, 1:08pm |
 |
@newsfilterio Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents $FOLD https://t.co/1iThc33DLm August 3rd 2021, 8:08am |
 |
@alpinestar17 RT @alpinestar17: $Fold is up almost 50%. Now we wait for $Bpro to do the numbers August 3rd 2021, 2:08am |
|
@Gambiste1 RT @chatwithcharles: @CryptoCobain $FOLD August 2nd 2021, 9:08pm |
 |
@chatwithcharles @CryptoCobain $FOLD August 2nd 2021, 8:08pm |
 |
@Waltblades So in learning about MEV there is another issue about scalability within that MEV network and $fold are working on… https://t.co/tIWgcwWvJ2 August 2nd 2021, 8:08pm |
 |
@EatCookCryptos $fold appears to be going to plan … next stop: NAMEK August 2nd 2021, 8:08pm |
 |
@swapski @0xSteez Manifold Finance $FOLD Look at the chart & get a good entry August 2nd 2021, 5:08pm |
 |
@bigcryptoe $FOLD FTW. https://t.co/fDOKZKOhVU August 2nd 2021, 5:08pm |
 |
@IOInvestors Amicus Therapeutics $FOLD Shares Inch Up After Receiving European Commission Approval for Galafold https://t.co/VhCrbxnUvM August 2nd 2021, 4:08pm |
 |
@degen_z ??? $bpro $fold https://t.co/Xq5912rbU7 August 2nd 2021, 4:08pm |
|
@alpinestar17 $Fold is up almost 50%. Now we wait for $Bpro to do the numbers August 2nd 2021, 4:08pm |
|
@swapski Yesterday evening I sold the top around $15 something Woke up this morning & bought the $FOLD dip ? Don’t sleep… https://t.co/nxrUS8Veo7 August 2nd 2021, 4:08pm |
|
@degen_z Great to see both $bpro and $fold doing well. Credit to @zer0sumgame1 who knows his game! https://t.co/q00X3m7hi8 August 2nd 2021, 3:08pm |
 |
@Gularfnm $FOLD Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fab… https://t.co/iogb9nI3HF August 2nd 2021, 2:08pm |
 |
@AJMacro Bought $FOLD shares at $9.41 https://t.co/o7dFQmD8uv August 2nd 2021, 1:08pm |
|
@MarcJacksonLA $FOLD Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fab… https://t.co/qKUjMS48XU August 2nd 2021, 1:08pm |
 |
@Briefingcom $FOLD: Amicus Therapeutics announces that the European Commission has approved Galafold for use in adolescents aged… https://t.co/OIaaVyidUQ August 2nd 2021, 1:08pm |
 |
@StckPro $FOLD NEW ARTICLE : Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents… https://t.co/K4RquSDwtA August 2nd 2021, 1:08pm |
 |
@Sarah_Katilyn $FOLD been trading sideways for so long, dippin and dabbin. https://t.co/MQHBDDBYe9 https://t.co/wbRzXtqh8L August 2nd 2021, 12:08pm |
 |
@UnusuallyActive AMICUS THERAPEUTICS SHARES UP 2.3% PREMARKET AFTER EUROPEAN COMMISSION APPROVES CO'S TREATMENT FOR ADOLESCENTS WITH FABRY DISEASE $FOLD August 2nd 2021, 12:08pm |
 |
@sbwcws Amicus announces European Comission approval of Galafold for adolescents $FOLD August 2nd 2021, 12:08pm |
 |
@WALLSTREETODDS_ MOVES HAPPENING NOW (8:08am) ? $FOLD is down 1.0% in the last 5 mins. ? There are 9 stocks that are up more than… https://t.co/qp6RypBR1N August 2nd 2021, 12:08pm |
 |
@wichitawarlock $EVK #lowfloat share buyback -will trade on tech only. $FOLD Galafold EU approval for Fabry disease. Mkt cap = 2.5bn. August 2nd 2021, 12:08pm |
|
@newsfilterio EC approves Amicus Therapeutics' Galafold for adolescents with Fabry disease $FOLD https://t.co/3IxrOOYYn8 August 2nd 2021, 11:08am |
|
@StckPro $FOLD NEW ARTICLE : EC approves Amicus Therapeutics' Galafold for adolescents with Fabry disease… https://t.co/tf5KQj7TXP August 2nd 2021, 11:08am |
 |
@ethanFlare $FOLD - EC approves Amicus Therapeutics' Galafold for adolescents with Fabry disease Cap size: mid, Float 82.6%, Sh… https://t.co/ma2gI5a2Cr August 2nd 2021, 11:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?